{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:53:41Z","timestamp":1787025221322,"version":"build-2736575974"},"reference-count":37,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Generalized pustular psoriasis is an inflammatory disease characterized by potentially life-threatening flares. This study assessed the economic burden of generalized pustular psoriasis in Finland by comparing healthcare resource utilization and both direct and indirect costs to population-based and psoriasis vulgaris control groups and between generalized pustular psoriasis patients with and without flares. Patients with \u2265\u20092 generalized pustular psoriasis diagnoses (ICD-10: L40.1) at a dermatology clinic in secondary healthcare and matched controls were identified during 1996\u20132019 from national registers. Direct costs were based on primary and secondary healthcare resource utilization and medications, and indirect costs on productivity loss due to sick leaves, disability pensions, and rehabilitation periods. All-cause annual direct costs were 3-fold higher in generalized pustular psoriasis (mean: \u20ac10,323) compared with population-based (\u20ac3,345; p\u2009&lt;\u20090.001), and psoriasis vulgaris controls (\u20ac3,569; p\u2009&lt;\u20090.001). Having flares was associated with 2.7-fold higher direct costs compared with no flares (cost ratio 2.7; 95% CI, 2.1\u20133.5; p\u2009&lt;\u20090.001), driven by higher hospitalization rates of patients with flares. Flares were also associated with 2.5-fold higher indirect costs (cost ratio 2.5; 95% CI, 1.6\u20134.0; p\u2009&lt;\u20090.001) compared with no flares. This first comprehensive economic evaluation of generalized pustular psoriasis highlights the substantial economic impact, in particular in patients with flares, and emphasizes costs due to work disability.<\/jats:p>","DOI":"10.2340\/actadv.v106.44671","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:07:32Z","timestamp":1770728852000},"page":"adv44671","source":"Crossref","is-referenced-by-count":1,"title":["Economic Burden of Generalized Pustular Psoriasis: A Population-based Register Study in Finland"],"prefix":"10.2340","volume":"106","author":[{"given":"Xavier","family":"Teitsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Huilaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirkka","family":"Koivusalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Meht\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino","family":"Vesikansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bregt","family":"Kappelhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gr\u00f6nman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Kaukua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Nuutinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"141226","doi-asserted-by":"crossref","unstructured":"Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis: a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol 2018; 27: 1067\u20131077.","DOI":"10.1111\/exd.13699"},{"key":"141227","doi-asserted-by":"crossref","unstructured":"Takeichi T, Akiyama M. Generalized pustular psoriasis: clinical management and update on autoinflammatory aspects. Am J Clin Dermatol 2020; 21: 227\u2013236.","DOI":"10.1007\/s40257-019-00492-0"},{"key":"141228","doi-asserted-by":"crossref","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2014; 53: 676\u2013684.","DOI":"10.1111\/ijd.12070"},{"key":"141229","doi-asserted-by":"crossref","unstructured":"Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 21\u201329.","DOI":"10.1007\/s40257-021-00654-z"},{"key":"141230","doi-asserted-by":"crossref","unstructured":"Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of palmoplantar pustulosis: a structured review. Expert Rev Clin Immunol 2020; 16: 253\u2013266.","DOI":"10.1080\/1744666X.2019.1708194"},{"key":"141231","doi-asserted-by":"crossref","unstructured":"Miyachi H, Konishi T, Kumazawa R, Matsui H, Shimizu S, Fushimi K, et al. Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol 2022; 86: 1266\u20131274.","DOI":"10.1016\/j.jaad.2021.06.008"},{"key":"141232","doi-asserted-by":"crossref","unstructured":"L\u00f6fvendahl S, Norlin JM, Schmitt-Egenolf M. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study. Br J Dermatol 2022; 186: 970\u2013976.","DOI":"10.1111\/bjd.20966"},{"key":"141233","doi-asserted-by":"crossref","unstructured":"Viguier M, Bentayeb M, Azzi J, de Pouvourville G, Gloede T, Langellier B, et al. Generalized pustular psoriasis: a nationwide population-based study using the National Health Data System in France. J Eur Acad Dermatol Venereol 2024; 38: 1131\u20131119.","DOI":"10.1111\/jdv.19901"},{"key":"141234","doi-asserted-by":"crossref","unstructured":"Haugaard JH, Thein D, Egeberg A. Prevalence and incidence of patients with generalized pustular psoriasis in Denmark: a nationwide registry-based study. JEADV Clinical Practice 2023; 2: 893\u2013900.","DOI":"10.1002\/jvc2.233"},{"key":"141235","doi-asserted-by":"crossref","unstructured":"Frysz M, Patel S, Li M, Griffiths C, Warren R, Ashcroft D. Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study. Br J Dermatol 2024; 191: 529\u2013538.","DOI":"10.1093\/bjd\/ljae217"},{"key":"141236","doi-asserted-by":"crossref","unstructured":"Prinz JC, Choon SE, Griffiths CEM, Merola JF, Morita A, Ashcroft DM, et al. Prevalence, comorbidities and mortality of generalized pustular psoriasis: a literature review. J Eur Acad Dermatol Venereol 2023; 37: 256\u2013273.","DOI":"10.1111\/jdv.18720"},{"key":"141237","doi-asserted-by":"crossref","unstructured":"Ericson O, L\u00f6fvendahl S, Norlin JM, Gyllensv\u00e4rd H, Schmitt-Egenolf M. Mortality in generalized pustular psoriasis: a population-based national register study. J Am Acad Dermatol 2023; 89: 616\u2013629.","DOI":"10.1016\/j.jaad.2023.04.066"},{"key":"141238","doi-asserted-by":"crossref","unstructured":"Sugiura K, Takemoto A, Yamaguchi M, Takahashi H, Shoda Y, Mitsuma T, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 2013; 133: 2514\u20132521.","DOI":"10.1038\/jid.2013.230"},{"key":"141239","doi-asserted-by":"crossref","unstructured":"Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med 2021; 385: 2431\u20132440.","DOI":"10.1056\/NEJMoa2111563"},{"key":"141240","doi-asserted-by":"crossref","unstructured":"Krueger J, Puig L, Tha\u00e7i D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 51\u201364.","DOI":"10.1007\/s40257-021-00658-9"},{"key":"141241","doi-asserted-by":"crossref","unstructured":"Navarini AA, Prinz JC, Morita A, Tsai TF, Viguier MA, Li L, et al. Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: results from the Effisayil 1 study. J Eur Acad Dermatol Venereol 2023; 37: 730\u2013736.","DOI":"10.1111\/jdv.18820"},{"key":"141242","doi-asserted-by":"crossref","unstructured":"Elewski BE, Lebwohl MG, Anadkat MJ, Barker J, Ghoreschi K, Imafuku S, et al. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study. J Am Acad Dermatol 2023; 89: 36\u201344.","DOI":"10.1016\/j.jaad.2023.02.040"},{"key":"141243","doi-asserted-by":"crossref","unstructured":"Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, et al. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. Lancet 2023; 402: 1541\u20131551.","DOI":"10.1016\/S0140-6736(23)01378-8"},{"key":"141244","doi-asserted-by":"crossref","unstructured":"Warren RB, Reich A, Kaszuba A, Placek W, Griffiths CEM, Zhou J, et al. Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial. Br J Dermatol 2023; 189: 161\u2013169.","DOI":"10.1093\/bjd\/ljad083"},{"key":"141245","doi-asserted-by":"crossref","unstructured":"Hanna ML, Singer D, Valdecantos WC. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Curr Med Res Opin 2021; 37: 735\u2013742.","DOI":"10.1080\/03007995.2021.1894108"},{"key":"141246","doi-asserted-by":"crossref","unstructured":"Tarride JE, Prajapati VH, Lynde C, Blackhouse G. The burden of palmoplantar pustulosis: aa Canadian population-based study of inpatient care, emergency departments, and outpatient clinics. JAAD Int 2023; 12: 151\u2013159.","DOI":"10.1016\/j.jdin.2023.04.002"},{"key":"141247","doi-asserted-by":"crossref","unstructured":"Morita A, Kotowsky N, Gao R, Shimizu R, Okubo Y. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: results from the Medical Data Vision claims database. J Dermatol 2021; 48: 1463\u20131473.","DOI":"10.1111\/1346-8138.16022"},{"key":"141248","doi-asserted-by":"crossref","unstructured":"L\u00f6fvendahl S, Norlin JM, Schmitt-Egenolf M. Economic burden of generalized pustular psoriasis in Sweden: a population-based register study. Psoriasis 2022; 12: 89\u201398.","DOI":"10.2147\/PTT.S359011"},{"key":"141249","doi-asserted-by":"crossref","unstructured":"Wolf P, Ceovic R, Conrad C, Falkensteiner K, Graier T, Ko\u0142t-Kami\u0144ska M, et al. Characteristics and management of generalized pustular psoriasis (GPP): experience from the Central and Eastern Europe (CEE) GPP Expert Network. J Eur Acad Dermatol Venereol 2024; 38: 1531\u20131542.","DOI":"10.1111\/jdv.19808"},{"key":"141250","doi-asserted-by":"crossref","unstructured":"L\u00f6fvendahl S, Norlin JM, Ericson O, Hanno M, Schmitt-Egenolf M. Prolonged sick leave before and after diagnosis of generalized pustular psoriasis: a Swedish population-based register study. Acta Derm Venereol 2023; 103: adv6497.","DOI":"10.2340\/actadv.v103.6497"},{"key":"141251","doi-asserted-by":"crossref","unstructured":"Hanna M, Singer D, Tang W, Zhou J, Macaulay D, Valdecantos WC, et al. PRO41 indirect burden of illness in patients with generalized pustular psoriasis in the United States. Value in Health 2020; 23: S696\u2013697.","DOI":"10.1016\/j.jval.2020.08.1777"},{"key":"141252","doi-asserted-by":"crossref","unstructured":"Zema CL, Valdecantos WC, Weiss J, Krebs B, Menter AM. Understanding flares in patients with generalized pustular psoriasis documented in US Electronic Health Records. JAMA Dermatol 2022; 158: 1142\u20131148.","DOI":"10.1001\/jamadermatol.2022.3142"},{"key":"141253","unstructured":"Kapiainen S, V\u00e4is\u00e4nen A, Haula T. Terveyden-ja sosiaalihuollon yksikk\u00f6kustannukset Suomessa vuonna 2011 [Internet] 2014. Available from: http: \/\/urn.fi\/URN: ISBN: 978-952-302-079-5"},{"key":"141254","doi-asserted-by":"crossref","unstructured":"Hanly P, Timmons A, Walsh PM, Sharp L. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value in Health 2012; 15: 429\u2013436.","DOI":"10.1016\/j.jval.2011.12.012"},{"key":"141255","unstructured":"Tilastokeskus. Tulorekisterin palkat ja palkkiotulot kuukausittain sukupuolen ja ik\u00e4ryhm\u00e4n mukaan muuttujina Kuukausi, Sukupuoli, Tulonsaajaryhm\u00e4, Ik\u00e4luokka, Tuloluokka, Tuloer\u00e4 ja Tiedot [Internet]. PxWeb [cited 2024 Jan 15]. Available from: https:\/\/pxdata.stat.fi:443\/PxWebPxWeb\/pxweb\/fi\/Kokeelliset_tilastot\/Kokeelliset_tilastot__trek\/koeti_trek_pxt_131w_fi.px\/"},{"key":"141256","doi-asserted-by":"crossref","unstructured":"Kuo CL, Duan Y, Grady J. Unconditional or conditional logistic regression model for age-matched case-control data? Front Public Health 2018; 6: 57.","DOI":"10.3389\/fpubh.2018.00057"},{"key":"141257","doi-asserted-by":"crossref","unstructured":"Koivusalo M, Teitsma X, Meht\u00e4l\u00e4 J, Vesikansa A, Capion SC, Airaksinen L, et al. Epidemiology, clinical characteristics, flares and mortality of generalized pustular psoriasis: a nationwide register study in Finland. Skin Health and Disease 2025; 5: 432\u2013442.","DOI":"10.1093\/skinhd\/vzaf076"},{"key":"141258","doi-asserted-by":"crossref","unstructured":"Tarride JE, Prajapati VH, Lynde C, Blackhouse G. The burden associated with generalized pustular psoriasis: a Canadian population-based study of inpatient care, emergency departments, and hospital- or community-based outpatient clinics. JAAD Int 2023; 12: 90\u201398.","DOI":"10.1016\/j.jdin.2023.03.012"},{"key":"141259","doi-asserted-by":"crossref","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 2014; 20: 327.","DOI":"10.3350\/cmh.2014.20.4.327"},{"key":"141260","doi-asserted-by":"crossref","unstructured":"Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis 2022; 17: 163.","DOI":"10.1186\/s13023-022-02299-5"},{"key":"141261","doi-asserted-by":"crossref","unstructured":"Laaksonen M, Gould R. Return to work after temporary disability pension in Finland. J Occup Rehabil 2015; 25: 471\u2013480.","DOI":"10.1007\/s10926-014-9554-1"},{"key":"141262","doi-asserted-by":"crossref","unstructured":"Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 31\u201338.","DOI":"10.1007\/s40257-021-00652-1"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/44671\/52832","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/44671\/52832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:07:42Z","timestamp":1770728862000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/44671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":37,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.44671","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}